Objective: To apply the Joint Royal College Ambulance Liaison Committee (JRCALC) checklist to patients who were deemed eligible for thrombolytic therapy on arrival in an Accident & Emergency Department (A&E) to determine the proportion suitable for prehospital thrombolysis. Design: Retrospective descriptive analysis. Methods: The clinical notes of all patients thrombolysed in an A&E department in a year were reviewed against the JRCALC guidelines for prehospital thrombolysis. Results: 14.2% of patients eligible for thrombolysis in a district general hospital were deemed suitable for prehospital thrombolysis according to the JRCALC criteria. The most common exclusion criteria were hyper/hypotension (50%), onset of symptoms (pain) .6 h previously (41.7%), or age .75 years (37%). Two or more contraindications to prehospital thrombolysis were present in 63.9% of patients. Conclusion: The JRCALC guidelines are an effective tool for identifying patients with potential contraindications to thrombolysis.
months pre-implementation at each site were compared to 16 months post-implementation data. Results: Median total hospital LOS fell by 404 min (95% CI: 370-437 min) from 1210mins (IQR: 511-3494) to 806mins (IQR: 368-2300). ED LOS fell from 230mins (IQR: 163-352) to 213mins (IQR 150-307). There was an absolute decrease in hospital admissions of 13.1% (95% CI: 12.3-13.9%) from 70.4% to 57.3%. 5815 patients were managed on the ADP, accounting for 23.2% (95% CI; 22.7-23.8%) of possible cardiac chest pain presentations and closely matching ADAPT. Conclusion: The ADAPT ADP is applicable to routine clinical practice across a broad range of hospitals. Implementation had a profound positive impact on hospital LOS and admission rates for patients presenting with possible cardiac chest pain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.